Position in KRYS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$255,485,957
+$130,181,642 QoQ
Shares Held
687,400
+41.7% QoQ
Ownership
2.32%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#11
of 419 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,963,376 across 304 Biotechnology names. KRYS ranks #18 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in KRYS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $255,485,957 | 687,400 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $125,304,315 | 485,074 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $130,655,104 | 529,955 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $82,449,748 | 467,058 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $35,929,706 | 261,383 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $74,078,238 | 410,861 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $79,811,846 | 509,459 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $79,776,285 | 438,259 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $110,210,627 | 600,145 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $117,187,900 | 658,618 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $53,018,653 | 427,363 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $29,719,896 | 256,206 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $38,148,777 | 324,947 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $849,436 | 10,610 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $786,020 | 9,922 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $710,521 | 10,194 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $458,044 | 6,976 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $630,333 | 9,473 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $566,944 | 8,105 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $220,273 | 4,219 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $286,892 | 4,219 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $286,511 | 3,719 | Shares | Sole | 2021-05-17 | |
| 2020-09-30 | $20,788,801 | 482,899 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $42,348,429 | 1,022,415 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $38,605,709 | 892,824 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||